FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986016280> ?p ?o ?g. }

• W2986016280 endingPage "1926" @default.
• W2986016280 startingPage "1926" @default.
• W2986016280 abstract "NLRP6 (NOD-like receptor family pyrin domain containing 6) is an important inflammasome component and is highly expressed in intestinal epithelial and in immune cells. NLRP6 mediated inflammasome activation plays a critical role in response to intestinal infection and preventing dysbiosis of gut microbiota through the secretion of IL-18 and mucus. However, we recently found that NLRP6 plays a pathogenic role in GVHD that is independent of microbial dysbiosis, which is in contrast to its well-appreciated microbiome-dependent protective role in intestinal colitis and tumorigenesis. Interestingly, we also found that activated T cells increased NLRP6 expression, but the T cell autonomousrole of NLRP6 in regulating T cell responses is unknown. Because NLRP6 is an important regulator of GVH responses, we tested the hypothesis that NLRP6 deficiency in donor T cells would ameliorate GVHD. To test our hypothesis, we first performed adetailed phenotypic analysis of various T cell subsets and activation markers in naïve NLRP6-/-and wild-type (WT) B6 animals and found a similar distribution of naïve, memory, effector and regulatory T cells. In order to examine whether the absence of NLRP6 in donors affects GVHD, WT-BALB/canimals were lethally irradiated (700cGy) and transplanted on day 0 with 5x106bone marrow and 1.0x106 splenic CD90+T cells from either syngeneic WT-BALB/c, allogeneic MHC-mismatched WT-B6 or NLRP6-/-animals. Contrary to our hypothesis, the recipients receiving donor T cells from NLRP6-/-animals showed a significantly worse survival compared to allogeneic WT-B6 animals (p<0.05). GVHD mortality and severity were also increased in an MHC mismatched B6 into B10.BR model, and in an MHC mismatched haploidentical B6 into F1model (p<0.05). In contrast, GVHD severity and mortality were similar in an MHC matched multiple minor antigen mismatched B6 into C3H.sw model. We hypothesized that GVHD severity and mortality was similar in the B6 into C3H.sw model because NLRP6 regulates CD4+ and CD8+ T cell responses, differently. In order to test this, we transplanted C3H.sw recipients as above except we infused either 1x106CD4+ or CD8+ T cells from B6-WT or NLRP6-/-animals. GVHD severity and mortality (P<0.05) were enhanced only when NLRP6-/-CD4+ T cells transplanted. We confirmed enhanced GVHD mortality and severity mediated by donor NLRP6-/-CD4+ T cells in a second MHC-mismatched GVHD model, B6 into BALB/c (p<0.05). To explore how NLRP6 effects T cell responses independent ofinflammasome activation, we tested naïve T cell proliferation in vitro after allogeneic or non-specific TCR stimulation by anti-CD3 and CD28 antibody and found that NLRP6-/-CD4+ but not CD8+T cells proliferated more than WT-B6 CD4+ or CD8+ T cells, respectively, following either stimulus. Furthermore, allogeneicNLRP6-/-T cells also caused greater mortality compared to WT allogenic T cells in a non-irradiated B6 into F1 model, which lacks inflammasome activation associated with conditioning induced DAMPs and PAMPs. Microarray analysis of activated T cells from NLRP6-/-animals showed higher expression of IL-2 and IFN-γ than WT B6 T cells, and we observed no effect of NLRP6 in a Treg suppression assay. These data suggest that NLRP6 regulates CD4+ T cell- mediated immune responses and that NLRP6 in donor T cells is critical for controlling CD4+ T cell mediated GVHD. The effect of NLRP6 on T cell mediated GVL is currently under investigation. Disclosures Tawara: Kyowa Hakko Kirin: Honoraria, Research Funding; Ono Pharmaceutical: Research Funding; Astellas Pharma: Research Funding. Ishizawa:Otsuka Pharmaceutical: Research Funding; Pfizer: Research Funding; Novartis: Speakers Bureau; Bristol-Myers Squibb: Speakers Bureau." @default.
• W2986016280 created "2019-11-22" @default.
• W2986016280 creator A5011224453 @default.
• W2986016280 creator A5038420195 @default.
• W2986016280 creator A5056287200 @default.
• W2986016280 creator A5065367171 @default.
• W2986016280 creator A5066620985 @default.
• W2986016280 creator A5071643003 @default.
• W2986016280 creator A5074939741 @default.
• W2986016280 creator A5078441495 @default.
• W2986016280 creator A5081878134 @default.
• W2986016280 date "2019-11-13" @default.
• W2986016280 modified "2023-10-16" @default.
• W2986016280 title "NLRP6 in Donor T Cells Separately Regulates CD4 and CD8 Mediated Graft-Versus-Host Disease in Experimental Murine BMT" @default.
• W2986016280 doi "https://doi.org/10.1182/blood-2019-123875" @default.
• W2986016280 hasPublicationYear "2019" @default.
• W2986016280 type Work @default.
• W2986016280 sameAs 2986016280 @default.
• W2986016280 citedByCount "0" @default.
• W2986016280 crossrefType "journal-article" @default.
• W2986016280 hasAuthorship W2986016280A5011224453 @default.
• W2986016280 hasAuthorship W2986016280A5038420195 @default.
• W2986016280 hasAuthorship W2986016280A5056287200 @default.
• W2986016280 hasAuthorship W2986016280A5065367171 @default.
• W2986016280 hasAuthorship W2986016280A5066620985 @default.
• W2986016280 hasAuthorship W2986016280A5071643003 @default.
• W2986016280 hasAuthorship W2986016280A5074939741 @default.
• W2986016280 hasAuthorship W2986016280A5078441495 @default.
• W2986016280 hasAuthorship W2986016280A5081878134 @default.
• W2986016280 hasBestOaLocation W29860162801 @default.
• W2986016280 hasConcept C154317977 @default.
• W2986016280 hasConcept C167672396 @default.
• W2986016280 hasConcept C202751555 @default.
• W2986016280 hasConcept C203014093 @default.
• W2986016280 hasConcept C2776914184 @default.
• W2986016280 hasConcept C2777209026 @default.
• W2986016280 hasConcept C2779972918 @default.
• W2986016280 hasConcept C28328180 @default.
• W2986016280 hasConcept C55493867 @default.
• W2986016280 hasConcept C86803240 @default.
• W2986016280 hasConcept C8891405 @default.
• W2986016280 hasConcept C95444343 @default.
• W2986016280 hasConceptScore W2986016280C154317977 @default.
• W2986016280 hasConceptScore W2986016280C167672396 @default.
• W2986016280 hasConceptScore W2986016280C202751555 @default.
• W2986016280 hasConceptScore W2986016280C203014093 @default.
• W2986016280 hasConceptScore W2986016280C2776914184 @default.
• W2986016280 hasConceptScore W2986016280C2777209026 @default.
• W2986016280 hasConceptScore W2986016280C2779972918 @default.
• W2986016280 hasConceptScore W2986016280C28328180 @default.
• W2986016280 hasConceptScore W2986016280C55493867 @default.
• W2986016280 hasConceptScore W2986016280C86803240 @default.
• W2986016280 hasConceptScore W2986016280C8891405 @default.
• W2986016280 hasConceptScore W2986016280C95444343 @default.
• W2986016280 hasIssue "Supplement_1" @default.
• W2986016280 hasLocation W29860162801 @default.
• W2986016280 hasOpenAccess W2986016280 @default.
• W2986016280 hasPrimaryLocation W29860162801 @default.
• W2986016280 hasRelatedWork W2016168268 @default.
• W2986016280 hasRelatedWork W2018916009 @default.
• W2986016280 hasRelatedWork W2054101033 @default.
• W2986016280 hasRelatedWork W2069307976 @default.
• W2986016280 hasRelatedWork W2164587311 @default.
• W2986016280 hasRelatedWork W2327592239 @default.
• W2986016280 hasRelatedWork W2981642747 @default.
• W2986016280 hasRelatedWork W3136031961 @default.
• W2986016280 hasRelatedWork W4308988935 @default.
• W2986016280 hasRelatedWork W4320717881 @default.
• W2986016280 hasVolume "134" @default.
• W2986016280 isParatext "false" @default.
• W2986016280 isRetracted "false" @default.
• W2986016280 magId "2986016280" @default.
• W2986016280 workType "article" @default.